CoChat
Sign Up
Cited by 1,041

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Using exosomes, naturally-equipped nanocarriers, for drug delivery

Batrakova, Elena V., Kim, Myung Soo·2015·Journal of Controlled Release
DOI 10.1016/j.jconrel.2015.07.030PMC PMC4656109
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2015.07.030

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 119

  1. Peng, 2013, Preformed albumin corona, a protective coating for nanoparticles based drug delivery system, Biomaterials, 43, 8521, 10.1016/j.biomaterials.2013.07.102 · DOI · Paper page
  2. Beckman, 1988, Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance, J. Biol. Chem., 263, 6884, 10.1016/S0021-9258(18)68727-7 · DOI
  3. Yoshida, 1992, Brain and tissue distribution of polyethylene glycol-conjugated superoxide dismutase in rats, Stroke, 23, 865, 10.1161/01.STR.23.6.865 · DOI
  4. Veronese, 2002, Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation, Adv. Drug Deliv. Rev., 54, 587, 10.1016/S0169-409X(02)00029-7 · DOI
  5. Dams, 2000, Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes, J. Pharmacol. Exp. Ther., 292, 1071, 10.1016/S0022-3565(24)35391-1 · DOI
  6. Ishida, 2003, Accelerated clearance of PEGylated liposomes in rats after repeated injections, J. Control. Release, 88, 35, 10.1016/S0168-3659(02)00462-5 · DOI
  7. Ishida, 2008, The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats, J. Control. Release, 126, 162, 10.1016/j.jconrel.2007.11.009 · DOI
  8. Garratty, 2008, Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion, Vox Sang., 94, 87, 10.1111/j.1423-0410.2007.01003.x · DOI
  9. Thery, 2009, Membrane vesicles as conveyors of immune responses, Nat. Rev. Immunol., 9, 581, 10.1038/nri2567 · DOI
  10. Alvarez-Erviti, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nat. Biotechnol., 29, 341, 10.1038/nbt.1807 · DOI · Paper page
  11. Bhatnagar, 2007, Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo, Blood, 110, 3234, 10.1182/blood-2007-03-079152 · DOI
  12. Clayton, 2005, Induction of heat shock proteins in B-cell exosomes, J. Cell Sci., 118, 3631, 10.1242/jcs.02494 · DOI
  13. Nolte-'t Hoen, 2009, Activated T cells recruit exosomes secreted by dendritic cells via LFA-1, Blood, 113, 1977, 10.1182/blood-2008-08-174094 · DOI
  14. Lai, 2015, Mesenchymal stem cell exosomes, Semin. Cell Dev. Biol., 40, 82, 10.1016/j.semcdb.2015.03.001 · DOI
  15. Song, 2014, Cardiac endothelial cell-derived exosomes induce specific regulatory B cells, Sci. Rep., 4, 7583, 10.1038/srep07583 · DOI
  16. Skogberg, 2015, Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens, Immunol. Cell Biol., 1
  17. Benito-Martin, 2015, The new deal: a potential role for secreted vesicles in innate immunity and tumor progression, Front. Immunol., 6, 66, 10.3389/fimmu.2015.00066 · DOI
  18. Marcus, 2013, FedExosomes: engineering therapeutic biological nanoparticles that truly deliver, Pharmaceuticals (Basel), 6, 659, 10.3390/ph6050659 · DOI
  19. Greening, 2015, A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods, Methods Mol Biol, 1295, 179, 10.1007/978-1-4939-2550-6_15 · DOI
  20. Chevillet, 2014, Quantitative and stoichiometric analysis of the microRNA content of exosomes, Proc. Natl. Acad. Sci. U. S. A., 111, 14888, 10.1073/pnas.1408301111 · DOI
  21. van der Pol, 2014, Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing, J. Thromb. Haemost., 12, 1182, 10.1111/jth.12602 · DOI
  22. Lotvall, 2014, Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles, J. Extracell. Vesicles, 3, 26913, 10.3402/jev.v3.26913 · DOI · Paper page
  23. Aalberts, 2012, Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans, Biol. Reprod., 86, 82, 10.1095/biolreprod.111.095760 · DOI
  24. Witwer, 2013, Standardization of sample collection, isolation and analysis methods in extracellular vesicle research, J. Extracell. Vesicles, 2, 10.3402/jev.v2i0.20360 · DOI
  25. Taylor, 2015, Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes, Methods, 10.1016/j.ymeth.2015.02.019 · DOI
  26. Lamparski, 2002, Production and characterization of clinical grade exosomes derived from dendritic cells, J. Immunol. Methods, 270, 211, 10.1016/S0022-1759(02)00330-7 · DOI
  27. Muller, 2014, Isolation of biologically-active exosomes from human plasma, J. Immunol. Methods, 411, 55, 10.1016/j.jim.2014.06.007 · DOI
  28. Taylor, 2011, Exosome isolation for proteomic analyses and RNA profiling, Methods Mol. Biol., 728, 235, 10.1007/978-1-61779-068-3_15 · DOI
  29. Liga, 2015, Exosome isolation: a microfluidic road-map, Lab Chip, 15, 2388, 10.1039/C5LC00240K · DOI
  30. He, 2014, Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology, Lab Chip, 14, 3773, 10.1039/C4LC00662C · DOI
  31. Im, 2014, Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor, Nat. Biotechnol., 32, 490, 10.1038/nbt.2886 · DOI
  32. Vaidyanathan, 2014, Detecting exosomes specifically: a multiplexed device based on alternating current electrohydrodynamic induced nanoshearing, Anal. Chem., 86, 11125, 10.1021/ac502082b · DOI
  33. Davies, 2012, Microfluidic filtration system to isolate extracellular vesicles from blood, Lab Chip, 12, 5202, 10.1039/c2lc41006k · DOI
  34. Sparks, 1992, Quantitative measurement of lipoprotein surface charge by agarose gel electrophoresis, J. Lipid Res., 33, 123, 10.1016/S0022-2275(20)41889-9 · DOI
  35. Wang, 2013, Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles, Lab Chip, 13, 2879, 10.1039/c3lc41343h · DOI
  36. Thery, 2011, Exosomes: secreted vesicles and intercellular communications, F1000 Biol. Rep., 3, 15, 10.3410/B3-15 · DOI · Paper page
  37. van der Pol, 2012, Classification, functions, and clinical relevance of extracellular vesicles, Pharmacol. Rev., 64, 676, 10.1124/pr.112.005983 · DOI
  38. Johnstone, 1992, The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins, Biochem. Cell Biol., 70, 179, 10.1139/o92-028 · DOI
  39. Mathivanan, 2009, ExoCarta: a compendium of exosomal proteins and RNA, Proteomics, 9, 4997, 10.1002/pmic.200900351 · DOI
  40. Zomer, 2010, Exosomes: fit to deliver small RNA, Commun. Integr. Biol., 3, 447, 10.4161/cib.3.5.12339 · DOI
  41. Wolfers, 2001, Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming, Nat. Med., 7, 297, 10.1038/85438 · DOI
  42. Chen, 2006, Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells, Eur. J. Immunol., 36, 1598, 10.1002/eji.200535501 · DOI
  43. Yang, 2011, Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model, PLoS One, 6, e22517, 10.1371/journal.pone.0022517 · DOI
  44. Le, 2014, miR-200-containing extracellular vesicles promote breast cancer cell metastasis, J. Clin. Invest., 124, 5109, 10.1172/JCI75695 · DOI
  45. Harris, 2015, Exosomes released from breast cancer carcinomas stimulate cell movement, PLoS One, 10, e0117495, 10.1371/journal.pone.0117495 · DOI
  46. Lv, 2014, Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein, Tumour Biol., 35, 10773, 10.1007/s13277-014-2377-z · DOI
  47. Prokopi, 2014, The secret role of microRNAs in cancer stem cell development and potential therapy: a notch-pathway approach, Front. Oncol., 4, 389
  48. Zhao, 2015, The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance, Cancer Lett., 356, 339, 10.1016/j.canlet.2014.10.027 · DOI
  49. Schorey, 2015, Exosomes and other extracellular vesicles in host-pathogen interactions, EMBO Rep., 16, 24, 10.15252/embr.201439363 · DOI
  50. Zitvogel, 1998, Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, Nat. Med., 4, 594, 10.1038/nm0598-594 · DOI
  51. Romagnoli, 2014, Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets, Front. Immunol., 5, 692
  52. Qazi, 2009, Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism, Blood, 113, 2673, 10.1182/blood-2008-04-153536 · DOI
  53. Kaur, 2014, CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells, Matrix Biol., 37, 49, 10.1016/j.matbio.2014.05.007 · DOI
  54. van der Grein, 2014, “Small Talk” in the innate immune system via RNA-containing extracellular vesicles, Front. Immunol., 5, 542, 10.3389/fimmu.2014.00542 · DOI
  55. Aucher, 2013, MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation, J. Immunol., 191, 6250, 10.4049/jimmunol.1301728 · DOI · Paper page
  56. Bruno, 2013, Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth, Stem Cells Dev., 22, 758, 10.1089/scd.2012.0304 · DOI
  57. Morelli, 2006, The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation, Am. J. Transplant., 6, 254, 10.1111/j.1600-6143.2005.01197.x · DOI
  58. Colino, 2007, Dendritic cell-derived exosomes express a Streptococcus pneumoniae capsular polysaccharide type 14 cross-reactive antigen that induces protective immunoglobulin responses against pneumococcal infection in mice, Infect. Immun., 75, 220, 10.1128/IAI.01217-06 · DOI
  59. Schnitzer, 2010, Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major, Vaccine, 28, 5785, 10.1016/j.vaccine.2010.06.077 · DOI
  60. Admyre, 2007, Exosomes with immune modulatory features are present in human breast milk, J. Immunol., 179, 1969, 10.4049/jimmunol.179.3.1969 · DOI
  61. Zonneveld, 2014, Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures, J. Extracell. Vesicles, 3, 10.3402/jev.v3.24215 · DOI
  62. Gyorgy, 2011, Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles, Cell. Mol. Life Sci., 68, 2667, 10.1007/s00018-011-0689-3 · DOI
  63. Lai, 2010, Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury, Stem Cell Res., 4, 214, 10.1016/j.scr.2009.12.003 · DOI · Paper page
  64. Arslan, 2013, Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury, Stem Cell Res., 10, 301, 10.1016/j.scr.2013.01.002 · DOI
  65. Lee, 2012, Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension, Circulation, 126, 2601, 10.1161/CIRCULATIONAHA.112.114173 · DOI
  66. Katsuda, 2013, Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes, Sci. Rep., 3, 1197, 10.1038/srep01197 · DOI
  67. Xin, 2014, Exosomes/miRNAs as mediating cell-based therapy of stroke, Front. Cell. Neurosci., 8, 377, 10.3389/fncel.2014.00377 · DOI
  68. Ilmer, 2014, Two sides of the same coin: stem cells in cancer and regenerative medicine, FASEB J., 28, 2748, 10.1096/fj.13-244640 · DOI
  69. Emanueli, 2015, Exosomes and exosomal miRNAs in cardiovascular protection and repair, Vasc. Pharmacol., 71, 24, 10.1016/j.vph.2015.02.008 · DOI
  70. Huang, 2015, Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?, Int. J. Biol. Sci., 11, 238, 10.7150/ijbs.10725 · DOI
  71. Sahoo, 2014, Exosomes and cardiac repair after myocardial infarction, Circ. Res., 114, 333, 10.1161/CIRCRESAHA.114.300639 · DOI
  72. Ibrahim, 2014, Exosomes as critical agents of cardiac regeneration triggered by cell therapy, Stem Cell Rep., 2, 606, 10.1016/j.stemcr.2014.04.006 · DOI
  73. Aminzadeh, 2015, Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy, Eur. Heart J., 36, 751, 10.1093/eurheartj/ehu196 · DOI
  74. Hergenreider, 2012, Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs, Nat. Cell Biol., 14, 249, 10.1038/ncb2441 · DOI
  75. Jeyaseelan, 2008, MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion, Stroke, 39, 959, 10.1161/STROKEAHA.107.500736 · DOI
  76. Lusardi, 2014, MicroRNA responses to focal cerebral ischemia in male and female mouse brain, Front. Mol. Neurosci., 7, 11, 10.3389/fnmol.2014.00011 · DOI
  77. Liu, 2013, microRNAs involved in regulating spontaneous recovery in embolic stroke model, PLoS One, 8, e66393, 10.1371/journal.pone.0066393 · DOI
  78. Tan, 2014, Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models, Stem Cell Res. Ther., 5, 76, 10.1186/scrt465 · DOI · Paper page
  79. Ding, 2012, Unconventional protein secretion, Trends Plant Sci., 17, 606, 10.1016/j.tplants.2012.06.004 · DOI
  80. Regente, 2012, Apoplastic exosome-like vesicles: a new way of protein secretion in plants?, Plant Signal. Behav., 7, 544, 10.4161/psb.19675 · DOI
  81. Ju, 2013, Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis, Mol. Ther., 21, 1345, 10.1038/mt.2013.64 · DOI
  82. Kalani, 2014, Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia, Life Sci., 107, 1, 10.1016/j.lfs.2014.04.018 · DOI
  83. Kalani, 2014, Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics, Mol. Neurobiol., 49, 590, 10.1007/s12035-013-8544-1 · DOI
  84. Sun, 2010, A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes, Mol. Ther., 18, 1606, 10.1038/mt.2010.105 · DOI
  85. Zhuang, 2011, Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain, Mol. Ther., 19, 1769, 10.1038/mt.2011.164 · DOI · Paper page
  86. Jang, 2013, Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors, ACS Nano, 7, 7698, 10.1021/nn402232g · DOI
  87. Tian, 2014, A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy, Biomaterials, 35, 2383, 10.1016/j.biomaterials.2013.11.083 · DOI
  88. Rani, 2015, Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications, Mol. Ther., 23, 812, 10.1038/mt.2015.44 · DOI
  89. Yang, 2015, Exosome delivered anticancer drugs across the blood–brain barrier for brain cancer therapy in Danio rerio, Pharm. Res., 32, 2003, 10.1007/s11095-014-1593-y · DOI
  90. Waldenstrom, 2012, Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells, PLoS One, 7, e34653, 10.1371/journal.pone.0034653 · DOI
  91. El Andaloussi, 2013, Exosomes for targeted siRNA delivery across biological barriers, Adv. Drug Deliv. Rev., 65, 391, 10.1016/j.addr.2012.08.008 · DOI
  92. Lee, 2012, Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy, Hum. Mol. Genet., 21, R125, 10.1093/hmg/dds317 · DOI
  93. Lai, 2012, Role of exosomes/microvesicles in the nervous system and use in emerging therapies, Front. Physiol., 3, 228, 10.3389/fphys.2012.00228 · DOI
  94. Ohno, 2013, Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells, Mol. Ther., 21, 185, 10.1038/mt.2012.180 · DOI · Paper page
  95. Kooijmans, 2013, Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles, J. Control. Release, 172, 229, 10.1016/j.jconrel.2013.08.014 · DOI · Paper page
  96. Wahlgren, 2012, Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes, Nucleic Acids Res., 40, e130, 10.1093/nar/gks463 · DOI
  97. van der Meel, 2014, Extracellular vesicles as drug delivery systems: lessons from the liposome field, J. Control. Release, 195, 72, 10.1016/j.jconrel.2014.07.049 · DOI
  98. Haney, 2015, Exosomes as drug delivery vehicles for Parkinson's disease therapy, J. Control. Release, 207, 18, 10.1016/j.jconrel.2015.03.033 · DOI · Paper page
  99. Jamur, 2010, Permeabilization of cell membranes, Methods Mol. Biol., 588, 63, 10.1007/978-1-59745-324-0_9 · DOI
  100. Pascucci, 2014, Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery, J. Control. Release, 192, 262, 10.1016/j.jconrel.2014.07.042 · DOI · Paper page
  101. Lv, 2012, Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro, J. Biol. Chem., 287, 15874, 10.1074/jbc.M112.340588 · DOI · Paper page
  102. Lee, 2015, Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration, Nano Lett., 15, 2938, 10.1021/nl5047494 · DOI
  103. Zhao, 2014, GDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse model, PLoS One, 9, e106867, 10.1371/journal.pone.0106867 · DOI
  104. Haney, 2012, Blood-borne macrophage-neural cell interactions hitchhike endosome networks for cell-based nanozyme brain delivery, Nanomedicine (Lond.), 7, 815, 10.2217/nnm.11.156 · DOI
  105. Zeelenberg, 2008, Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses, Cancer Res., 68, 1228, 10.1158/0008-5472.CAN-07-3163 · DOI
  106. Haney, 2013, Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases, PLoS One, 8, e61852, 10.1371/journal.pone.0061852 · DOI
  107. Shtam, 2013, Exosomes are natural carriers of exogenous siRNA to human cells in vitro, Cell Commun. Signal., 11, 88, 10.1186/1478-811X-11-88 · DOI · Paper page
  108. Pan, 2012, Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi), Gut, 61, 1330, 10.1136/gutjnl-2011-300449 · DOI
  109. Liu, 2013, Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development, Protein Cell, 4, 932, 10.1007/s13238-013-3092-z · DOI
  110. Nordin, 2015, Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties, Nanomedicine, 11, 879, 10.1016/j.nano.2015.01.003 · DOI
  111. Yeo, 2012, Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery, Adv. Drug Deliv. Rev., 65, 336, 10.1016/j.addr.2012.07.001 · DOI · Paper page
  112. Ban, 2015, Low pH increases the yield of exosome isolation, Biochem. Biophys. Res. Commun., 461, 76, 10.1016/j.bbrc.2015.03.172 · DOI
  113. Portner, 2005, Bioreactor design for tissue engineering, J. Biosci. Bioeng., 100, 235, 10.1263/jbb.100.235 · DOI · Paper page
  114. Muller, 2006, Gene therapy: can neural stem cells deliver?, Nat. Rev. Neurosci., 7, 75, 10.1038/nrn1829 · DOI
  115. Chen, 2011, Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs, J. Transl. Med., 9, 47, 10.1186/1479-5876-9-47 · DOI
  116. Mignot, 2006, Prospects for exosomes in immunotherapy of cancer, J. Cell. Mol. Med., 10, 376, 10.1111/j.1582-4934.2006.tb00406.x · DOI
  117. Escudier, 2005, Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial, J. Transl. Med., 3, 10, 10.1186/1479-5876-3-10 · DOI
  118. Morse, 2005, A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer, J. Transl. Med., 3, 9, 10.1186/1479-5876-3-9 · DOI
  119. Dai, 2008, Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer, Mol. Ther., 16, 782, 10.1038/mt.2008.1 · DOI

Cited by

Sorted by citations

See all 1,041

Metadata

Authors
Batrakova, E. V., & Kim, M. S.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2015-12
Volume
219
Pages
396-405
ISSN
0168-3659
DOI
10.1016/j.jconrel.2015.07.030
PMC
PMC4656109
Cited by
1,041
References
8
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
United States National Institutes of Health (1RO1 NS057748)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review